Skip to main content
. 2020 Oct 17;6(1):128–137. doi: 10.1016/j.ekir.2020.10.011

Table 3.

Characteristics of immunosuppressive treatments upon discharge after kidney transplantation (M0)

Characteristics Total
(n = 354)
Induction therapy, n (%)
 Basiliximab 193 (54.5)
 Antithymocyte globulin 160 (45.2)
 with i.v. Ig 6 (1.7)
 Basiliximab + antithymocyte globulin 1 (0.3)
Maintenance therapy, n (%)
 MMF + tacrolimus 240 (67.8)
 MMF + cyclosporine 97 (27.4)
 MMF + everolimus 1 (0.3)
 Tacrolimus + everolimus 14 (4.0)
 Tacrolimus + azathioprine 2 (0.6)

MMF, mycophenolate mofetil.